Aptorum Group Limited (NASDAQ:APM) Short Interest Update

Aptorum Group Limited (NASDAQ:APM) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 41,000 shares, a drop of 58.4% from the March 31st total of 98,500 shares. Based on an average daily volume of 2,340,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 1.9% of the company’s shares are sold short.

Aptorum Group Trading Down 1.4 %

NASDAQ:APM opened at $5.48 on Friday. Aptorum Group has a 1-year low of $1.35 and a 1-year high of $17.49. The stock has a fifty day simple moving average of $6.18 and a 200 day simple moving average of $3.34.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.